Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients

American Journal of Kidney Diseases

Volumn 42, Issue 3, 2003, Pages 524-531

  Lin, Chun Liang ^b   Huang, Chiu Ching ^b   Yu, Chun Chen ^b   Yang, Huan Yu ^b   Chuang, Feng Rong ^b   Yang, Chih Wei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Advanced glycation end products (AGEs); End stage renal disease (ESRD); On line hemodiafiltration (HDF)

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH FLUX HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ON LINE HEMODIAFILTRATION; PLASMA CLEARANCE; TECHNIQUE; UREMIA;

EID: 0041358512     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00747-9     Document Type: Article

References (30)

1. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
2. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55:389-399, 1999
3. Miyata T, Notoya K, Yoshida K, et al: Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260-270, 1997
4. Miyata T, Inagi R, Wada Y, et al: Glycation of human beta2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33:12215-12221, 1994
5. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 93:521-528, 1994
6. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci U S A 89:12043-12047, 1992
7. Beisswenger PJ, Moore LL, Brinck-Johnsen T, Curphey TJ: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
8. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci U S A 93:2353-2358, 1996
9. Yan SD, Yan SF, Chen X, et al: Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1:693-699, 1995
10. Ritz E, Deppisch R, Nawroth P: Toxicity of uraemia - Does it come of AGE? Nephrol Dial Transplant 9:1-2, 1994
11. Raj DS, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: A nephrologist's perspective. Am J Kidney Dis 35:365-380, 2000
12. Canaud B, Bosc JY, Leray H, et al: On-line hemodiafiltration: State of the art. Nephrol Dial Transplant 135:S3-S11, 1998 (suppl 5)
13. Maeda K, Kobayakawa H, Fujita Y, et al: Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder joint pain in long-term dialysis patients. Artif Organs 14:321-327, 1990
14. Makita Z, Bucala R, Rayfield EJ, et al: Reactive glycosylation end products in diabetic uremia and treatment of renal failure. Lancet 343:1519-1522, 1994
15. Lambert MF, Wood J: Incorporating patient preferences into randomized trials. J Clin Epidemiol 53:163-166, 2000
16. Daugirdas JT, Ing TS: Handbook of Dialysis. Boston, MA, Little Brown, 1994, p 95
17. Wei SS, Paganini EP, Cressman MD, Wright E: Use of hemodiafiltration to enhance delivered dialysis. ASAIO J 40:977-980, 1994
18. Makita Z, Vlassara H, Cerami A, et al: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
19. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
20. Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S: Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46: 1881-1887, 1997
21. Vlassara H, Fuh H, Donnelly T, Cybulsky M: Advanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447-456, 1995
22. Makita Z, Radoff S, Rayfield EJ, et al: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
23. Fishbane S, Bucala R, Pereira BJ, Founds H, Vlassara H: Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia. Kidney Int 52:1645-1650, 1997
24. Baz M, Durand C, Ragon A, et al: Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 14:681-685, 1991
25. 2-microglobulin levels in chronic hemodialysis patients. Blood Purif 19:301-307, 2001
26. Hsu PY, Yang CW, Chien CC, Lin CL, Huang CC: Effects of ultrapure dialysis fluid on inflammatory parameters in chronic hemodialysis patients. Presented at Annual Meeting of Taiwan Society of Nephrology, ROC, Taipei, Taiwan, December, 1, 2001 (abstr)
27. Miyata T, Ueda Y, Yamada Y, et al: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 9:2349-2356, 1998
28. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 55:286-293, 1999
29. Gerdemann A, Wagner Z, Solf A, et al: Plasma levels of advanced glycation end products during hemodialysis, hemodiafiltration and hemofiltration: Potential importance of dialysate quality. Nephrol Dial Transplant 17:1045-1049, 2002
30. Schwedler SB, Metzger T, Schinzel R, Wanner C: Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 62:301-310, 2002